Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Solid pharmaceutical dosage formulation

Solid pharmaceutical dosage formulation

US Patent 8377952 · Granted Feb 19, 2013

Estimated economic value: $8,193,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Extended local release of anti-CSFR1 antibodies2025
Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-pip2024
High concentration formulations of anti-CSF1 and anti-CSF1R antibodies2024
Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-pip2024
Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-pip2024
Stable protein solution formulation containing high concentration of an anti-VEG2024
Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-pip2024
Targeted delivery of anti-CSF1R antibodies to joints with tenosynovial giant cel2023
Immediate release pharmaceutical formulation of 4-[3-(4- cyclopropanecarbonyl-pi2023
Aqueous pharmaceutical formulation of tapentadol for oral administration2023
Extended local release of anti-CSFR1 antibodies2022
High concentration formulations of anti-CSF1 and anti-CSF1R antibodies2022